---
$id: https://graph.org.ai/products/commodity/51151543
$type: Product
source: UNSPSC
code: "51151543"
title: "Neostigmine bromide"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Neostigmine bromide

**UNSPSC Code**: 51151543
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C12H19N2O2.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 005SYP50G5, chemically known as carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium bromide but more generally known as neostigmine bromide, which bears US NIH Compound Identifier 8246. European Medicines Agency schedules Neostigmine bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09195MIG. The term NEOSTIGMINE BROMIDE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule neostigmine bromide under HS 29242995 and SITC 51479. As of Q4 2014, NEOSTIGMINE BROMIDE remains US FDA's Preferred Term for this commodity. Neostigmine bromide bears US NLM identifiers UMLS ID C0282261 and NCI Concept Code C76612. SMILES: CN(C)C(=O)OC1CCCC(C1)[N+](C)(C)C.[BR-].

